112 related articles for article (PubMed ID: 1313267)
21. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
McNeill JH; Brenner MJ; Muschek LD
Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
[No Abstract] [Full Text] [Related]
22. Bronchodilatory activity and pharmacokinetics of new xanthines in guinea-pigs.
Takagi K; Hasegawa T; Nadai M; Sakai R; Miyamoto K
Clin Exp Pharmacol Physiol; 1992 Jun; 19(6):447-56. PubMed ID: 1318809
[TBL] [Abstract][Full Text] [Related]
23. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
Oger S; Behr-Roussel D; Gorny D; Denys P; Lebret T; Alexandre L; Giuliano F
Eur Urol; 2007 Mar; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cyclic GMP phosphodiesterase by xanthine derivatives relaxes guinea-pig trachealis smooth muscle.
Tanaka H; Ogawa K; Takagi K; Satake T; Hidaka H
Clin Exp Pharmacol Physiol; 1991 Mar; 18(3):163-8. PubMed ID: 1647281
[TBL] [Abstract][Full Text] [Related]
25. Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle.
Moriuchi H; Nakahara T; Maruko T; Sakamoto K; Ishii K
Eur J Pharmacol; 2003 May; 470(1-2):57-64. PubMed ID: 12787831
[TBL] [Abstract][Full Text] [Related]
26. Selective bronchodilators from 1-(5'-oxohexyl)xanthines.
Miyamoto KI; Sakai R; Yamamoto Y; Konno K; Sanae F; Hasegawa T; Takagi K
J Pharm Pharmacol; 1992 Nov; 44(11):888-92. PubMed ID: 1361531
[TBL] [Abstract][Full Text] [Related]
27. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.
Kapui Z; Schaeffer P; Mikus EG; Boronkay E; Gyürky J; Herbert JM; Pascal M
Arzneimittelforschung; 1999 Aug; 49(8):685-93. PubMed ID: 10483515
[TBL] [Abstract][Full Text] [Related]
28. Correlations of PDE-4 inhibition between enzymes of smooth muscle and inflammatory cell sources.
Cariuk P; Cavalla D; Chasin M; Giembycz M
Cell Biochem Biophys; 1998; 28(2-3):219-49. PubMed ID: 9515167
[TBL] [Abstract][Full Text] [Related]
29. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
Mushlin P; Boerth RC; Wells JN
Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
[No Abstract] [Full Text] [Related]
30. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
[No Abstract] [Full Text] [Related]
31. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
32. Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
Harris AL; Connell MJ; Ferguson EW; Wallace AM; Gordon RJ; Pagani ED; Silver PJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):199-206. PubMed ID: 2552074
[TBL] [Abstract][Full Text] [Related]
33. Effects of alkyl substitutions of xanthine skeleton on bronchodilation.
Sakai R; Konno K; Yamamoto Y; Sanae F; Takagi K; Hasegawa T; Iwasaki N; Kakiuchi M; Kato H; Miyamoto K
J Med Chem; 1992 Oct; 35(22):4039-44. PubMed ID: 1331453
[TBL] [Abstract][Full Text] [Related]
34. PDE4 inhibitors: new xanthine analogues.
Montana JG; Cooper N; Dyke HJ; Gowers L; Gregory JP; Hellewell PG; Miotla J; Morris K; Naylor R; Tuladhar B; Warneck JB
Bioorg Med Chem Lett; 1998 Oct; 8(20):2925-30. PubMed ID: 9873649
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
Birk S; Edvinsson L; Olesen J; Kruuse C
Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
[TBL] [Abstract][Full Text] [Related]
36. Bronchodilator activity of a nonxanthine phosphodiesterase inhibitor; 2,4-diamino-5-cyano-6-bromopyridine (compound I).
Smith PF; Thompson WJ; de Haën C; Halonen M; Palmer JD; Johnson DG
J Pharmacol Exp Ther; 1986 Apr; 237(1):114-9. PubMed ID: 2420965
[TBL] [Abstract][Full Text] [Related]
37. Relaxant effect of C-type natriuretic peptide on guinea-pig tracheal smooth muscle.
Takagi K; Araki N; Suzuki K
Arzneimittelforschung; 1992 Nov; 42(11):1329-31. PubMed ID: 1337250
[TBL] [Abstract][Full Text] [Related]
38. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
Semmler J; Gebert U; Eisenhut T; Moeller J; Schönharting MM; Alléra A; Endres S
Immunology; 1993 Apr; 78(4):520-5. PubMed ID: 8388363
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
[TBL] [Abstract][Full Text] [Related]
40. Relaxant effects of atrial natriuretic polypeptide on guinea pig tracheal smooth muscle.
Watanabe H; Takagi K; Satake T
Prog Biochem Pharmacol; 1988; 23():136-41. PubMed ID: 2847186
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
